Case Report
Unilateral pleural effusion as the sole presentation of ovarian hyperstimulation syndrome (OHSS)
Tarique Salman*, Suruchi Mohan and Yasmin Sana
Published: 03 December, 2020 | Volume 3 - Issue 2 | Pages: 182-184
A 44-year-old G4P2+1 presented to the emergency department on the 10th day following embryo transfer (with two fresh, day 5, blastocysts transferred in a hospital abroad) with the complaints of difficulty breathing, chest discomfort and cough for one day. These symptoms increased on lying on her side and were not related to exertion. She also mentioned having had abdominal discomfort over the preceding few days. On taking a past history, the patient revealed that all her prior pregnancies were the result of IVF treatment and she suffered OHSS with each. Her first pregnancy was a triplet gestation through IVF and complicated by OHSS; followed by her second pregnancy which was an IVF twin gestation also complicated by OHSS with ascites requiring paracentesis. With her third IVF treatment she conceived, had OHSS and miscarried spontaneously. However, these IVF treatments and pregnancies were all managed abroad and no medical records were available.
Read Full Article HTML
DOI: 10.29328/journal.cjog.1001074
Cite this Article
Read Full Article PDF
Keywords:
10.29328/journal.cjog.1001074
References
- Elchalal U, Schenker J. The pathophysiology of ovarian hyperstimulation syndrome- Views and ideas. Hum Reprod. 1997; 12: 1129-1137. PubMed: https://pubmed.ncbi.nlm.nih.gov/9221989/
- Roden S, Justin K, Hamasson J, Israël-Biet D. An uncommon etiology of isolated pleural effusion: the ovarian hyperstimulation syndrome. Chest. 2000; 118: 256-258.
- Daniel Y, Yaron Y, Oren M, Peyser MR, Lessing JB. Ovarian hyperstimulation syndrome manifests as acute unilateral hydrothorax. Hum Reprod. 1995; 10: 1684-1685.
- Friedler S, Rachstien A, Bukovsky I, Ron-El R, Raziel A. Unilateral hydrothorax as a sole and recurrent manifestation in ovarian hyperstimulation syndrome following in vitro fertilization. Hum Repro. 1998; 13: 859-861. PubMed: https://pubmed.ncbi.nlm.nih.gov/9619537/
- Johnston R, Loo R. Hepatic Hydrothorax, studies to determine the source of the fluid and report of thirteen cases. Ann Inter Med. 1946; 61: 385-401. PubMed: https://pubmed.ncbi.nlm.nih.gov/14218925/
- Light R, Macgregor M, Luchsinger P, Ball WC, Jr. Pleural effusion; the diagnostic separation of transudate and exudate. Ann Inter Med. 1972; 77: 507-513. PubMed: https://pubmed.ncbi.nlm.nih.gov/4642731/
- Das M, Son W, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rate of ovarian hyperstimulation syndrome. Reprod Biomed Online. 2014; 29: 545-551. PubMed: https://pubmed.ncbi.nlm.nih.gov/25262236/
- Lainas GT, Lainas TG, Sfontouris IA, Venetis CA, Kyprianou MA, et al. A decision making algorithm for preforming or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with HCG. Human Repro Open. 2020; 2020: hoaa013. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275634/
- Braam S, Consten D, Smeenk L, Cohlen BJ, Curfs MHJM, et al. In Vitro Maturation of Oocytes in Women at Risk of Ovarian Hyperstimulation - A Prospective Multicenter Cohort Study. Int J Fertil Steril. 2019; 13: 38-44. PubMed: https://pubmed.ncbi.nlm.nih.gov/30644243/
- Zhang J, Merhi Z, Yang M, Bodri D, Chavez-Badiola A, et al. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial. Am J Obstet Gynecol. 2016; 214: 96.e1-8. PubMed: https://pubmed.ncbi.nlm.nih.gov/26259908/
- Ovarian hyperstimulation syndrome. Paper number HFEA (24/01/2018) 867.2018.
- Dyer S, Chembers G, De Mouzon J, Nygren KG, Zegers-Hochschild F, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010. Human Reprod. 2016; 31: 1588-1609. PubMed: https://pubmed.ncbi.nlm.nih.gov/27207175/
Figures: